Caris Life Sciences Inc NASDAQ NMS - GLOBAL MARKET:CAI
The leadership team, board of directors, and 10% beneficial owners of Caris Life Sciences Inc, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Brille Brian J
—500,000 sharesCASTLEMAN PETER M
—100,000 sharesDenton John Russel
—9,184 sharesGilliam Joseph E
—16,129 sharesHALBERT DAVID D
—121,025,002 sharesHALBERT JON
—625,000 sharesJ H Whitney VI L P
—7,739,781 sharesJOHANSEN LAURA I
—330,705 sharesKnowles Jonathan Kenneth Charles
—307,379 sharesPOSTE GEORGE
—307,594 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.